CV Sciences, Inc. isn't one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to CV Sciences' Fourth Quarter and Year ...

CV Sciences reported a challenging third quarter for 2025, marked by a 16% decline in revenue year-over-year to $3.3 million. Despite a slight improvement in gross margin, the company posted a net ...

Greetings, and welcome to the CV Sciences' 2025 Fiscal Year-End and Fourth Quarter Earnings Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to ...

In the latest earnings call, CV Sciences (OTC: CVSI) announced a Q3 2024 revenue of $3.9 million, on par with previous quarters but slightly down from the same quarter last year.

Operator: Greetings. Welcome to the CV Sciences Fourth Quarter and Year End 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A brief question and ...

Greetings, and welcome to the CV Sciences Third Quarter 2025 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your ...

Operator: Greetings, and welcome to CV Sciences’ First Quarter 2025 Earnings Conference Call. At this time, participants are in a listen only mode. A question and answer session will follow the formal ...